Suppr超能文献

人高密度脂蛋白受体清道夫受体 BI 的功能基因组学:老狗有新把戏。

Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: an old dog with new tricks.

机构信息

Department of Medicine, Division of Endocrinology, Metabolism & Clinical Nutrition, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

出版信息

Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):124-31. doi: 10.1097/MED.0b013e32835ed575.

Abstract

PURPOSE OF REVIEW

The athero-protective role of scavenger receptor BI (SR-BI) is primarily attributed to its ability to selectively transfer cholesteryl esters from high-density lipoproteins (HDLs) to the liver during reverse cholesterol transport (RCT). In this review, we highlight recent findings that reveal the impact of SR-BI on lipid levels and cardiovascular disease in humans. Moreover, additional responsibilities of SR-BI in modulating adrenal and platelet function, as well as female fertility in humans, are discussed.

RECENT FINDINGS

Heterozygote carriers of P297S, S112F and T175A-mutant SR-BI receptors were identified in patients with high HDL-cholesterol levels. HDL from P297S-SR-BI carriers was unable to mediate macrophage cholesterol efflux, whereas hepatocytes expressing P297S-SR-BI were unable to mediate the selective uptake of HDL-cholesteryl esters. S112F and T175A-mutant receptors exhibited similar impaired cholesterol transport functions in vitro. Reduced SR-BI function in P297S carriers was also associated with decreased steroidogenesis and altered platelet function. Further, human population studies identified SCARB1 variants associated with female infertility.

SUMMARY

Identification of SR-BI variants confirms the key role of this receptor in influencing lipid levels and RCT in humans. A deeper understanding of the contributions of SR-BI to steroidogenesis, platelet function and fertility is required in light of exploration of HDL-raising therapies aimed at reducing cardiovascular risk.

摘要

目的综述

清道夫受体 BI(SR-BI)的抗动脉粥样硬化作用主要归因于其在胆固醇逆向转运(RCT)过程中能够将胆固醇酯从高密度脂蛋白(HDL)选择性地转移到肝脏。在这篇综述中,我们强调了最近的发现,这些发现揭示了 SR-BI 对人类脂质水平和心血管疾病的影响。此外,还讨论了 SR-BI 在调节肾上腺和血小板功能以及人类生育能力方面的额外作用。

最新发现

在具有高 HDL-胆固醇水平的患者中发现了 P297S、S112F 和 T175A 突变型 SR-BI 受体的杂合子携带者。来自 P297S-SR-BI 携带者的 HDL 无法介导巨噬细胞胆固醇流出,而表达 P297S-SR-BI 的肝细胞无法介导 HDL 胆固醇酯的选择性摄取。体外 S112F 和 T175A 突变型受体表现出相似的胆固醇转运功能受损。P297S 携带者中 SR-BI 功能降低也与类固醇生成减少和血小板功能改变有关。此外,人类群体研究鉴定出与女性不育相关的 SCARB1 变体。

总结

鉴定出 SR-BI 变体证实了该受体在影响人类脂质水平和 RCT 中的关键作用。鉴于正在探索旨在降低心血管风险的升高 HDL 治疗方法,需要更深入地了解 SR-BI 对类固醇生成、血小板功能和生育能力的贡献。

相似文献

引用本文的文献

2
Lipoprotein receptor signalling in atherosclerosis.载脂蛋白受体信号通路与动脉粥样硬化
Cardiovasc Res. 2020 Jun 1;116(7):1254-1274. doi: 10.1093/cvr/cvz338.
3
miRNAs and High-Density Lipoprotein metabolism.微小RNA与高密度脂蛋白代谢
Biochim Biophys Acta. 2016 Dec;1861(12 Pt B):2053-2061. doi: 10.1016/j.bbalip.2016.01.021. Epub 2016 Feb 9.
6
Scavenger receptors in homeostasis and immunity.清道夫受体在稳态和免疫中的作用。
Nat Rev Immunol. 2013 Sep;13(9):621-34. doi: 10.1038/nri3515. Epub 2013 Aug 9.
7
New developments in selective cholesteryl ester uptake.选择性胆固醇酯摄取的新进展。
Curr Opin Lipidol. 2013 Oct;24(5):386-92. doi: 10.1097/MOL.0b013e3283638042.

本文引用的文献

5
Rationale for cholesteryl ester transfer protein inhibition.胆固醇酯转移蛋白抑制的理由。
Curr Opin Lipidol. 2012 Aug;23(4):372-6. doi: 10.1097/MOL.0b013e328353ef1d.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验